Original Articles

Effects of U-50 488H, a kappa-agonist, on action potentials of isolated ventricular papillary muscle of guinea pigs

Jian-zhong Shen, Hui Dong, Tak-ming Wong


Trans(+-)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl) cyclohexyl]-benzeneacetamide-methanesulfonate-hydrate (U-50 488H), a specific kappa-agonist, at 1-10 mumol.L-1 caused concentration-dependent reductions in the action potential duration at 50% and 90% of repolarization (APD50 and APD90) without modifying the resting potential (RP), the action potential amplitude (APA) and the maximal upstroke velocity (Vmax). The effects were attenuated by (-)-(1R,5R,9R)-5,9-diethyl-2-(3-furylmethyl)-2L-hydroxy-6,7-benzomorphan (M(r) 2266 BS, 1 mumol.L-1), a specific kappa-antagonist which itself had no effect on the action potentials of the ventricular papillary muscle of guinea pigs, indicating that U-50 488H at 1-10 mumol.L-1 acts via specific cardiac kappa-receptors. At 100 mumol.L-1, U-50 488H not only shortened APD50 and APD90, but also reduced RP, APA, and Vmax, which were not attenuated by Mr 2266 BS (1 mumol.L-1) suggesting that the effects of U-50 488H at 100 mumol.L-1 were probably nonspecific

Article Options

Download Citation

Cited times in Scopus